Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

NICE Reassessing Old CDF Drugs On Value-For-Money Basis – Some Fail

22 Aug 2016

• By Sten Stovall

SC1608_Assessment-magnifying glass_1200x675

Related Content

New UK Cancer Drugs Fund Dismays Pharma, Charities

01 Aug 2016

Related Companies

Pfizer Inc.

Eli Lilly and Company

Johnson & Johnson

Novartis AG

Bayer AG

Additional Topics

United Kingdom Europe Cost Effectiveness Health Technology Assessment Reimbursement Drug Review Pricing Strategies Commercial Cancer BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.